Davis Blaine 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Sale
Common Stock
2026-01-06$6.82/sh−10,591$72,227→ 121,220 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.